NKX6-1 and colorectal carcinoma: We recently demonstrated the abnormal methylation of NK6 homeobox 1 (NKX6.1) in CRC and found that NKX6.1 methylation was an independent indicator of 5-year disease-free survival in stage II CRC patients receiving adjuvant chemotherapy [12].